The Australian sleep apnea devices market generated approximately USD 149 million in 2023, anticipated to grow at an 8.3% CAGR to reach USD 260.5 million by 2030, with therapeutic devices (especially masks) dominating the segment. Rising OSA prevalence, home‑care adoption, and innovations like AI-driven CPAPs and compact travel units are key growth catalysts in Australia and New Zealand. https://www.datamintelligence.com/research-report/australia-sleep-apnea-devices-market